Tigecycline-induced acute pancreatitis: case report and literature review

International Journal of Antimicrobial Agents

Volumn 34, Issue 5, 2009, Pages 486-489

  Hung, Whitney Y ^a   Kogelman, Laura ^a   Volpe, Gretchen ^a   Iafrati, Mark ^a   Davidson, Lisa ^a  

^a TUFTS MEDICAL CENTER   (United States)

Author keywords

Adverse drug reaction; Pancreatitis; Tigecycline

Indexed keywords

CIPROFLOXACIN; CLINDAMYCIN; DAPTOMYCIN; MEROPENEM; PENICILLIN G; SULFONAMIDE; TIGECYCLINE; VANCOMYCIN;

ABDOMINAL PAIN; ACUTE PANCREATITIS; AGED; AMYLASE BLOOD LEVEL; ARTICLE; CASE REPORT; CLOSTRIDIUM DIFFICILE INFECTION; COAGULASE NEGATIVE STAPHYLOCOCCUS; CORYNEBACTERIUM DIPHTHERIAE; DEBRIDEMENT; DIARRHEA; DRUG ERUPTION; DRUG HYPERSENSITIVITY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; EOSINOPHIL COUNT; FEMALE; FEMOROPOPLITEAL BYPASS; HUMAN; LEUKOCYTE COUNT; LIMB ISCHEMIA; MACULOPAPULAR RASH; NAUSEA AND VOMITING; PERIPHERAL VASCULAR DISEASE; PRIORITY JOURNAL; REOPERATION; SKIN INFECTION; STAPHYLOCOCCUS EPIDERMIDIS; TRIACYLGLYCEROL LIPASE BLOOD LEVEL; UNSPECIFIED SIDE EFFECT; WOUND INFECTION;

AGED; ANTI-BACTERIAL AGENTS; FEMALE; HUMANS; MINOCYCLINE; PANCREATITIS; SKIN DISEASES, BACTERIAL;

EID: 70249102076     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2009.05.004     Document Type: Article

References (15)

1. ® (package insert). Philadelphia, PA: Wyeth Pharmaceutics; 2009.
2. Gilson M., Moachon L., Jeanne L., Dumaine V., Eyrolle L., Morand P., et al. Acute pancreatitis related to tigecycline: case report and review of the literature. Scand J Infect Dis 40 (2008) 681-683
3. Lipshitz J., Kruh J., Cheung P., and Cassagnol M. Tigecycline-induced pancreatitis. J Clin Gastroenterol 43 (2009) 93
4. Marshall S.R. Tigecycline-induced pancreatitis. Hosp Pharm 44 (2009) 239-241
5. Balani A.R., and Grendell J.H. Drug-induced pancreatitis. Drug Saf 31 (2008) 823-837
6. Nicolau D.P., Mengedoht D.E., and Kline J.J. Tetracycline-induced pancreatitis. Am J Gastroenterol 86 (1991) 1669-1671
7. Elmore M.F., and Rogge J.D. Tetracycline-induced pancreatitis. Gastroenterology 81 (1981) 1134-1136
8. Kunelis C.T., Peters J.L., and Edmondson H.A. Fatty liver of pregnancy and its relationship to tetracycline therapy. Am J Med 38 (1965) 359-377
9. Steinberg W.M. Acute drug and toxin induced pancreatitis. Hosp Pract 20 (1985) 95-102
10. MacDonald H., Kelly R.G., Allen E.S., Noble J.F., and Kanegis L.A. Pharmacokinetic studies on minocycline in man. Clin Pharmacol Ther 14 (1972) 852-861
11. Sacchidanand S., Penn R.L., Embil J.M., Campos M.E., Curcio D., Cllis-Grosse E., et al. Efficacy and safety of tigecycline monotherapy compared with vancomycin plus aztreonam in patients with complicated skin and skin structure infections: results from a phase III randomized double-blind trial. Int J Infect Dis 9 (2005) 251-261
12. Florescu I., Beuran M., Dimov R., Razbadauskas A., Bochan M., Fichev G., et al. Efficacy and safety of tigecycline compared with vancomycin or linezolid for treatment of serious infections with methicillin-resistant Staphylococcus aureus or vancomycin-resistant enterococci: a Phase 3, multicenter, double-blind, randomized study. J Antimicrob Chemother 62 Suppl. 1 (2008) i17-i28
13. Vasilev K., Reshedko G., Orasan R., Sanchez M., Teras J., Babinchak T., et al. A Phase 3, open-label, non-comparative study of tigecycline in the treatment of patients with selected serious infections due to resistant Gram-negative organisms including Enterobacter species, Acinetobacter baumannii and Klebsiella pneumoniae. J Antimicrob Chemother 62 Suppl. 1 (2008) i29-i40
14. Bergallo C., Jasovich A., Teglia O., Oliva M.E., Lentnek A., Wouters L., et al. Safety and efficacy of intravenous tigecycline in treatment of community-acquired pneumonia: results from a double-blind randomized Phase 3 comparison study with levofloxacin. Diagn Microbiol Infect Dis 63 (2009) 52-61
15. Naranjo C.A., Shear N.H., and Lanctot K.L. Advances in the diagnosis of adverse drug reactions. J Clin Pharmacol 32 (1992) 897-904